Austin, May 07, 2025 (GLOBE NEWSWIRE) -- Preclinical Imaging Market Trends & Growth Analysis:
According to SNS Insider, the Preclinical Imaging Market size was valued at USD 4.18 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.69% to reach USD 6.31 billion by 2032.
The preclinical imaging market is expected to witness consistent growth in the forecast years because of increased investments in research and development, advancements in imaging systems technology, and increasing demand for non-invasive techniques in drug discovery and disease research. Use of multimodal imaging and growth in preclinical studies in oncology and neurology also contribute to market growth in pharmaceutical and biotechnology industries.
Get a Sample Report of Preclinical Imaging Market@ https://www.snsinsider.com/sample-request/6103
The U.S. Preclinical Imaging Market was estimated at USD 1.05 billion in 2023 and is expected to reach USD 1.45 billion by 2032, at a CAGR of 3.72% during the forecast period of 2024-2032. The U.S. leads the North American preclinical imaging market due to its strong research infrastructure, high R&D spending, and market leadership of major pharmaceutical and biotech companies. In addition, the early adoption of advanced imaging technologies further solidifies its leading position in the region.
Key Preclinical Imaging Companies Profiled in the Report
- PerkinElmer, Inc. – IVIS Spectrum, Quantum GX2 microCT
- MR Solutions – MRS PET/CT, MRS 7T MRI
- Siemens A.G. – Inveon PET/SPECT/CT
- General Electric (GE) – Triumph PET/SPECT/CT
- Mediso Ltd. – nanoScan PET/MRI, nanoScan SPECT/CT
- Molecubes – β-CUBE (PET), γ-CUBE (SPECT), X-CUBE (CT)
- TriFoil Imaging – eXplore CT, Triumph II
- FUJIFILM SonoSite – Vevo 3100 (High-Frequency Ultrasound)
- MILabs B.V. – VECTor PET/SPECT/CT
- Bruker Corporation – BioSpec MRI, Albira PET/SPECT/CT
- Agilent Technologies – MRI and spectroscopy solutions for preclinical research
Preclinical Imaging Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | US$ 4.18 billion |
| Market Size by 2032 | US$ 6.31 billion |
| CAGR | CAGR of 4.69% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
Segmentation Analysis
By Product, Optical Imaging Segment Dominates the Market, Multimodal Imaging Segment to Register Fastest Growth
The optical imaging segment led the preclinical imaging market with 11.9% market share in 2023 because of its high sensitivity, affordability, and lack of invasiveness. It is widely used in small animal imaging for applications such as tumor detection, gene expression analysis, and drug discovery. Optical imaging techniques such as bioluminescence and fluorescence imaging are convenient to use and provide quick results, hence appropriate for routine preclinical studies. The ability to provide real-time imaging with low risk has stimulated their mass usage within academic research centers and biotechnology companies engaged in early-stage drug discovery and the pathophysiology of diseases.
The multimodal imaging segment is expected to see the fastest growth in the preclinical imaging market over the forecast period due to the capability of combining the strengths of two or more imaging modalities. With combinations of modalities such as PET/CT, SPECT/CT, and PET/MRI, multimodal systems provide complementary anatomical and functional data, providing a better integrated picture of disease processes. This integrated information is increasingly vital for drug discovery and translational medicine. Additionally, the demand for precise quantitative imaging data and the expanding application of hybrid systems in complex disease modeling and monitoring of therapy are fueling this segment's uptake.
By Application, the Research & Development Segment Dominates the Market
The research & development segment led the preclinical imaging market in 2023, attributed to the growing emphasis on drug discovery in early stages, disease pathophysiology research studies, and assessment of the efficacy of therapies. Pharmaceutical and biotech companies, as well as research and academic organizations, are investing heavily in preclinical trials to take innovative drugs to market in the shortest possible time. Preclinical imaging facilitates non-invasive, longitudinal monitoring of biological events in animal models, enhancing research outcome efficiency and accuracy. Growing chronic disease cases and the need for personalized medicine further drive demand for advanced imaging devices in R&D settings, solidifying its market leadership.
By End-Use, Pharma and Biotech Companies Segment Dominates the Market
In 2023, the pharma and biotech companies segment led the market with 35.9% market share because of their heavy utilization of imaging technologies in drug development and discovery procedures. The biotech and pharma companies depend on preclinical imaging to study mechanisms of disease, evaluate drug effectiveness, and monitor toxicity in animal models before human trials. The growing emphasis on precision medicine, along with pressures to receive faster and more accurate preclinical information, has led to increased investments in complicated imaging systems. There are regulatory pressures for drug efficacy and safety that support the market segment's dominance in growth.
For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ https://www.snsinsider.com/request-analyst/6103
Preclinical Imaging Market Segmentation
By Product
- CT Imaging
- MRI Imaging
- PET/SPECT Imaging
- Multi-modal Imaging
- Optical Imaging
- Ultrasound Imaging
- Photoacoustic Imaging
- Reagents
- Services
By Application
- Research and Development
- Drug Discovery
By End-Use
- Pharma and Biotech Companies
- Research Institutes
- Others
Regional Insights
North America Dominates the Preclinical Imaging Market, Asia Pacific Expected to Register Fastest Growth
North America dominated the preclinical imaging market with 28.3% market share in 2023, due to the presence of leading research institutions, well-established pharmaceutical firms, and continued government and private investment in biomedical research. The adoption of leading-edge imaging technologies, including micro-MRI and PET systems, and favorable regulatory support for preclinical research by the region largely contributes to its position. In addition, the heightened emphasis on drug discovery and translational research continues to drive market demand.
Asia Pacific will be the fastest-growing region in the preclinical imaging market in the forecast period, as a result of the increased biotechnology and pharmaceutical sectors in China, India, and South Korea. Expansion in healthcare expenditures, increased disease awareness at the early stages, and increased spending on life sciences research are accelerating the adoption of sophisticated imaging modalities in the region. Encouragement of biomedical R&D by the government is also accelerating the market's growth.
Buy a Single-User PDF of Preclinical Imaging Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/6103
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Preclinical Imaging Market by Product
8. Preclinical Imaging Market by Application
9. Preclinical Imaging Market by End-Use
11. Regional Analysis
12. Company Profiles
13. Use Cases and Best Practices
14. Conclusion
Related Reports
Molecular Imaging Market Report
Clinical Trial Imaging Market Report
Digital Pathology Market Report
Small Animal Imaging (In Vivo) Market Report
AI In Medical Imaging Market Report
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
